Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse. A growing clinical problem?

Arch Intern Med. 1990 Jan;150(1):89-93.

Abstract

Over an 18-month period, the incidence of group A beta-hemolytic streptococcal bacteremia rose from an average of 2.5 per 10,000 patient discharges to 17.9. A retrospective analysis was performed comparing patients with group A beta-hemolytic streptococcal bacteremia during this 18-month period with those who presented over the preceding 36 months. Most of the increased incidence was attributable to individuals hospitalized with a diagnosis of drug addiction who had concomitant soft-tissue infection, although the absolute number of hospitalized drug addicts did not change during this interval. No common or distinctive group A streptococcal serotypic patterns were discovered. This experience suggests that group A beta-hemolytic streptococcal bacteremia and soft-tissue infection may present in epidemic fashion among parenteral drug addicts in the absence of a common source.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Cluster Analysis
  • Female
  • Humans
  • Incidence
  • Male
  • Philadelphia / epidemiology
  • Retrospective Studies
  • Sepsis / epidemiology
  • Sepsis / etiology*
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / etiology*
  • Streptococcus pyogenes / isolation & purification
  • Substance Abuse, Intravenous / complications*